异丙托溴铵杂质A, Ipratropium impurity A

Ketorolac trometamol for peak identification

氨丁三醇

trans-4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-α,α-diphenyl-1-piperidinebutanamide 1-oxide monohydrate, Loperamide oxide monohydrate

甲氨蝶呤杂质D, Methotrexate impurity D

Mycophenolate Mofetil

霉酚酸酯

Neostigmine Methyl Sulfate

N,N,N-三甲基-2-[(二甲氨基)甲酰氧基]苯铵甲磺酸盐

Ondansetron impurity D

昂丹司琼杂质D

p-Divinylbenzene

对二乙烯苯

Paroxetine for system suitability

帕罗西汀

Pramipexole Dihydrochloride Monohydrate

茴香油, Pseudoisoeugenyl 2-methylbutyrate for peak identification

Risperidone

利培酮

Sodium L-lactate-¹³C₃ solution

L-乳酸钠-¹³C₃ 溶液

Sulindac

舒林酸

2,2′-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine], Terazosin impurity E